Wealth Enhancement Advisory Services
AXSM icon

Wealth Enhancement Advisory Services’s Axsome Therapeutics AXSM Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.03M Buy
23,674
+3,755
+19% +$817K 0.01% 1226
2026
Q2 		$4.66M Buy
19,919
+739
+4% +$160K 0.01% 1054
2026
Q1 		$3.23M Sell
19,180
-2,578
-12% -$445K 0.01% 1133
2025
Q4 		$3.74M Buy
21,758
+253
+1% +$35.3K 0.01% 1168
2025
Q3 		$2.55M Buy
21,505
+827
+4% +$93.2K ﹤0.01% 1307
2025
Q2 		$2.18M Buy
20,678
+34
+0.2% +$3.6K ﹤0.01% 1314
2025
Q1 		$2.41M Buy
20,644
+1,017
+5% +$116K ﹤0.01% 1152
2024
Q4 		$1.66M Sell
19,627
-181
-0.9% -$16.6K ﹤0.01% 1269
2024
Q3 		$1.78M Buy
19,808
+754
+4% +$65.8K ﹤0.01% 1115
2024
Q2 		$1.53M Buy
19,054
+9
+0% +$666 ﹤0.01% 1097
2024
Q1 		$1.52M Buy
19,045
+130
+0.7% +$10.9K ﹤0.01% 1068
2023
Q4 		$1.51M Buy
+18,915
New +$1.26M ﹤0.01% 1001

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
Iridian Asset Management
Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return
Baldwin Wealth Partners
Baldwin Wealth Partners Marion, Massachusetts $1.52B AUM 21.45% 1-Year Est. Return
Washington Trust Advisors
Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Stanley-Laman Group
Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Wealth Enhancement Advisory Services's AXSM Position: Q3 2026 in Review

Wealth Enhancement Advisory Services increased its Axsome Therapeutics (AXSM) stake by 19% in Q3 2026, buying an estimated $817K and bringing the position to 23,674 shares worth $4.03M. The position accounts for 0.01% of the portfolio, ranked #1226.

Wealth Enhancement Advisory Services first reported a position in AXSM in Q4 2023 and has held it in 12 quarters since. The position peaked at $4.66M in Q2 2026. 89 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Wealth Enhancement Advisory Services held 23,674 shares of Axsome Therapeutics worth $4.03M as of Q3 2026.
  • Wealth Enhancement Advisory Services bought 3,755 Axsome Therapeutics shares in Q3 2026, an estimated $817K.
  • Axsome Therapeutics made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #1226 holding.
  • Wealth Enhancement Advisory Services first reported a position in Axsome Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • Wealth Enhancement Advisory Services's Axsome Therapeutics position peaked at $4.66M in Q2 2026.
  • 89 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.